Longeveron (LGVN) FCF Margin (QoQ) (2020 - 2026)
Longeveron (LGVN) FCF Margin (QoQ) (2020 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - |
| 10 | Longeveron | 14.87 Bn | 14.86 Bn | 264,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 35,297.00 |
| Dec 31, 2025 | 228,043.00 |
| Sep 30, 2025 | -254,215.00 |
| Jun 30, 2025 | 5,065.00 |
| Mar 31, 2025 | -67,837.00 |
| Dec 31, 2024 | -13,811.00 |
| Sep 30, 2024 | 59,411.00 |
| Jun 30, 2024 | -45,146.00 |
| Mar 31, 2024 | 603,870.00 |
| Dec 31, 2023 | -356,543.00 |
| Sep 30, 2023 | -87,666.00 |
| Jun 30, 2023 | -5,156.00 |
| Mar 31, 2023 | -14,913.00 |
| Dec 31, 2022 | 265,002.00 |
| Sep 30, 2022 | -389,247.00 |
| Jun 30, 2022 | 63,499.00 |
| Mar 31, 2022 | -59,232.00 |
| Dec 31, 2021 | 25,978.00 |
| Sep 30, 2021 | -41,830.00 |
| Jun 30, 2021 | 20,270.00 |